[ad_1] Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to…
BMY
-
-
STOCK MARKET
GSK to buy asthma drug developer for up to $1.4 billion in pipeline push
by userby user[ad_1] GSK on Tuesday said it had struck a deal to acquire asthma drug developer…
-
[ad_1] (Updated with Friday’s closing prices.) The U.S. stock market staged a remarkable rally in…
-
STOCK MARKET
Fusion Pharma climbs as radiopharmaceutical company flagged as potential merger target
by userby user[ad_1] Fusion Pharmaceuticals Inc.’s stock was up by 5.3% in premarket trading on Wednesday, as…
-
STOCK MARKET
Karuna Therapeutics’ stock hits record territory after Bristol Myers’ $14 billion buyout deal
by userby user[ad_1] Shares of Karuna Therapeutics Inc. KRTX, +47.29% rocketed 48% into record territory in premarket…
-
STOCK MARKET
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
by userby user[ad_1] Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a…
-
STOCK MARKET
Medicare drug price negotiations move forward with all drugmakers participating, White House says
by userby user[ad_1] All of the primary manufacturers of the 10 drugs selected in August for Medicare…
-
STOCK MARKET
Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
by userby user[ad_1] Medicare on Tuesday announced the first 10 drugs to be selected for a price-negotiation…
-
STOCK MARKET
‘Millions of women suffering in silence’: Female workers want menopause benefits, so why are they so rare?
by userby user[ad_1] Not enough workplaces recognize menopause as a legitimate reason to take sick days or…
-
[ad_1] Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday,…
- 1
- 2